These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36882732)

  • 1. Factors associated with relapse and hospital death in patients coinfected with visceral leishmaniasis and HIV: a longitudinal study.
    Costa LDLN; Lima US; Rodrigues V; Lima MIS; Silva LA; Ithamar J; Azevedo CMPS
    BMC Infect Dis; 2023 Mar; 23(1):141. PubMed ID: 36882732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania-HIV co-infection: clinical presentation and outcomes in an urban area in Brazil.
    Cota GF; de Sousa MR; de Mendonça AL; Patrocinio A; Assunção LS; de Faria SR; Rabello A
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2816. PubMed ID: 24743472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India.
    Mahajan R; Das P; Isaakidis P; Sunyoto T; Sagili KD; Lima MA; Mitra G; Kumar D; Pandey K; Van Geertruyden JP; Boelaert M; Burza S
    Clin Infect Dis; 2015 Oct; 61(8):1255-62. PubMed ID: 26129756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India.
    Sinha PK; van Griensven J; Pandey K; Kumar N; Verma N; Mahajan R; Kumar P; Kumar R; Das P; Mitra G; Flevaud L; Ferreyra C; Remartinez D; Pece M; Palma PP
    Clin Infect Dis; 2011 Oct; 53(7):e91-8. PubMed ID: 21890763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Efficacy of Secondary Prophylaxis Against Visceral Leishmaniasis in Human Immunodeficiency Virus Coinfected Patients Over the Past 10 Years in Eastern India.
    Goswami RP; Goswami RP; Basu A; Ray Y; Rahman M; Tripathi SK
    Am J Trop Med Hyg; 2017 Feb; 96(2):285-291. PubMed ID: 27879457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Risk and Predictors of Visceral Leishmaniasis Relapse in Human Immunodeficiency Virus-Coinfected Patients in Ethiopia: A Retrospective Cohort Study.
    Abongomera C; Diro E; Vogt F; Tsoumanis A; Mekonnen Z; Admassu H; Colebunders R; Mohammed R; Ritmeijer K; van Griensven J
    Clin Infect Dis; 2017 Oct; 65(10):1703-1710. PubMed ID: 29020196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral leishmaniasis and HIV coinfection in Latin America.
    Lindoso JA; Cota GF; da Cruz AM; Goto H; Maia-Elkhoury AN; Romero GA; de Sousa-Gomes ML; Santos-Oliveira JR; Rabello A
    PLoS Negl Trop Dis; 2014 Sep; 8(9):e3136. PubMed ID: 25233461
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    van Griensven J; Mengesha B; Mekonnen T; Fikre H; Takele Y; Adem E; Mohammed R; Ritmeijer K; Vogt F; Adriaensen W; Diro E
    Front Cell Infect Microbiol; 2018; 8():94. PubMed ID: 29651411
    [No Abstract]   [Full Text] [Related]  

  • 9. Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome).
    Burza S; Mahajan R; Sinha PK; van Griensven J; Pandey K; Lima MA; Sanz MG; Sunyoto T; Kumar S; Mitra G; Kumar R; Verma N; Das P
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3053. PubMed ID: 25101665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring prognosis in chronic relapsing visceral leishmaniasis among HIV-infected patients: Circulating Leishmania DNA.
    Cota GF; de Sousa MR; de Assis TSM; Pinto BF; Rabello A
    Acta Trop; 2017 Aug; 172():186-191. PubMed ID: 28501450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of relapse of visceral leishmaniasis in inner São Paulo State, Brazil.
    Simão JC; Victória C; Fortaleza CMCB
    Int J Infect Dis; 2020 Jun; 95():44-49. PubMed ID: 32088340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral leishmaniasis and HIV/AIDS in Brazil: Are we aware enough?
    Leite de Sousa-Gomes M; Romero GAS; Werneck GL
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005772. PubMed ID: 28945816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of serum cytokine levels in symptomatic and asymptomatic HIV-Leishmania coinfected individuals from a Brazilian visceral leishmaniasis endemic area.
    Guedes DL; Silva EDD; Castro MCAB; Júnior WLB; Ibarra-Meneses AV; Tsoumanis A; Adriaensen W; van Griensven J; Pereira VRA; Medeiros ZM
    PLoS Negl Trop Dis; 2022 Jun; 16(6):e0010542. PubMed ID: 35714136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral leishmaniasis treatment outcome and its determinants in northwest Ethiopia.
    Welay GM; Alene KA; Dachew BA
    Epidemiol Health; 2016; 39():e2017001. PubMed ID: 28092934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New world Leishmania spp. infection in people living with HIV: Concerns about relapses and secondary prophylaxis.
    Araújo CF; Oliveira IBN; Silva MVT; Pereira LIA; Pinto SA; Silveira MB; Dorta ML; Fonseca SG; Gomes RS; Ribeiro-Dias F
    Acta Trop; 2021 Dec; 224():106146. PubMed ID: 34562423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymptomatic Leishmania infection in HIV-positive outpatients on antiretroviral therapy in Pernambuco, Brazil.
    Guedes DL; Justo AM; Barbosa Júnior WL; Silva EDD; Aquino SR; Lima Junior MSDC; Montarroyos U; Bezerra GSN; Vieira AVB; Pereira VRA; Medeiros ZM
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0009067. PubMed ID: 33476331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia.
    Diro E; Edwards T; Ritmeijer K; Fikre H; Abongomera C; Kibret A; Bardonneau C; Soipei P; Mutinda B; Omollo R; van Griensven J; Zijlstra EE; Wasunna M; Alves F; Alvar J; Hailu A; Alexander N; Blesson S
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007132. PubMed ID: 30789910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral leishmaniasis in Northeast Brazil: What is the impact of HIV on this protozoan infection?
    Silva de Lima UR; Vanolli L; Moraes EC; Ithamar JS; Azevedo CMPES
    PLoS One; 2019; 14(12):e0225875. PubMed ID: 31805100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
    ter Horst R; Collin SM; Ritmeijer K; Bogale A; Davidson RN
    Clin Infect Dis; 2008 Jun; 46(11):1702-9. PubMed ID: 18419422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral leishmaniasis and leishmaniasis-HIV coinfection: comparative study.
    Coutinho JVSC; Santos FSD; Ribeiro RDSP; Oliveira IBB; Dantas VB; Santos ABFS; Tauhata JR
    Rev Soc Bras Med Trop; 2017; 50(5):670-674. PubMed ID: 29160515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.